Elevated expression of TG2 has been found in secondary metastatic tumors of glioblastoma [67], pancreatic carcinoma [68], RCC [69], breast carcinoma [70], lung carcinoma [71], melanoma [72], and ovarian carcinoma [73]. Here, TGM2 is linked to metastatic neoplasm.